Integrity Alliance’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Integrity Alliance's REGN Position: Q2 2026 in Review
Integrity Alliance increased its Regeneron Pharmaceuticals (REGN) stake by 8% in Q2 2026, buying an estimated $26.5K and bringing the position to 528 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #641.
Integrity Alliance first reported a position in REGN in Q1 2025 and has held it in 4 quarters since. The position peaked at $579K in Q1 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Integrity Alliance held 528 shares of Regeneron Pharmaceuticals worth $329K as of Q2 2026.
- Integrity Alliance bought 39 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $26.5K.
- Regeneron Pharmaceuticals made up 0.01% of Integrity Alliance's portfolio in Q2 2026, its #641 holding.
- Integrity Alliance first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
- Integrity Alliance's Regeneron Pharmaceuticals position peaked at $579K in Q1 2025.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.